Published in Am J Pathol on April 01, 1981
Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest (1985) 2.58
Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A (1984) 2.28
Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest (1985) 2.16
Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med (1987) 1.95
Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest (1988) 1.60
Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes. J Clin Invest (1982) 1.43
Platelet-activating factor stimulates metabolism of phosphoinositides in horse platelets: possible relationship to Ca2+ mobilization during stimulation. Proc Natl Acad Sci U S A (1983) 1.25
Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest (1997) 1.16
Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat. Br J Pharmacol (1988) 1.13
Anaphylactic actions of platelet-activating factor. Am J Pathol (1981) 1.12
Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. Am J Pathol (1981) 1.11
Role of platelets in neuroinflammation: a wide-angle perspective. J Neuroinflammation (2010) 1.11
Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases. J Exp Med (1988) 1.07
Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Biochem J (1984) 0.92
Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit. Am J Pathol (1985) 0.90
Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophils. Proc Natl Acad Sci U S A (1987) 0.86
Neutropenia induced by systemic infusion of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid: correlation with its in vitro effects upon neutrophils. J Clin Invest (1982) 0.85
Biosynthesis of platelet-activating factor by cultured rat Kupffer cells stimulated with calcium ionophore A23187. Biochem J (1989) 0.84
Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung. Br J Pharmacol (1991) 0.84
Lipid characteristics in metastatic cells. Clin Exp Metastasis (1999) 0.83
The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation. Agents Actions (1984) 0.83
Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia. Immunology (1983) 0.82
Aggregation of rat neutrophils by nucleotide triphosphates. Br J Pharmacol (1982) 0.80
Mechanisms of calcium homeostasis in the polymorphonuclear leucocyte. Agents Actions (1986) 0.80
Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells. Biochem J (1989) 0.79
Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response. J Leukoc Biol (2014) 0.79
Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia. Basic Res Cardiol (1985) 0.78
Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Am J Pathol (1981) 0.77
Determination of the platelet activating factor in silicotic patients and its effect on fibroblasts. Environ Health Prev Med (2001) 0.75
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature (1980) 9.25
Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids (1966) 6.31
Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest (1978) 5.80
Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med (1972) 5.38
Immune complex disease in experimental animals and man. Adv Immunol (1973) 5.30
Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest (1977) 5.16
Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem (1979) 4.31
Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest (1977) 4.08
Calcium-induced lysozyme secretion from human polymorphonuclear leukocytes. Biochem Biophys Res Commun (1974) 3.24
Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets. J Exp Med (1971) 2.92
[Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine]. C R Seances Acad Sci D (1979) 2.53
Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet (1980) 2.47
Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol (1979) 2.31
Neutrophil aggregation and swelling induced by chemotactic agents. J Immunol (1977) 2.26
Release of vasoactive amines from rabbit platelets induced by sensitized mononuclear leukocytes and antigen. J Exp Med (1970) 2.22
The sequential release of granule constitutents from human neutrophils. J Immunol (1980) 2.09
Concanavalin A induces microtubule assembly and specific granule discharge in human polymorphonuclear leukocytes. J Cell Biol (1976) 2.08
Glycerophospholipid synthesis: improved general method and new analogs containing photoactivable groups. Proc Natl Acad Sci U S A (1977) 2.07
The release of a platelet-activating factor by stimulated rabbit neutrophils. J Immunol (1979) 2.02
An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance. Prostaglandins (1974) 2.02
Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils. Nature (1974) 1.97
Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem Biophys Res Commun (1979) 1.94
The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol (1975) 1.92
Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes. Am J Pathol (1978) 1.91
Arachidonic acid causes sudden death in rabbits. Science (1974) 1.91
Human neutrophil-derived platelet activating factor. J Immunol (1980) 1.82
Selective neutrophil desensitization to chemotactic factors. J Cell Biol (1979) 1.77
Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation. Blood (1980) 1.77
Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J Immunol (1980) 1.77
Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion. J Immunol (1977) 1.76
Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. J Biol Chem (1980) 1.61
Isolation of a chemical trigger for thrombosis. Prostaglandins (1974) 1.57
Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils. J Immunol (1980) 1.55
Antigen induced histamine release from platelets of rabbits producing homologous PCA antibody. Proc Soc Exp Biol Med (1966) 1.51
Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response. J Exp Med (1976) 1.48
Destruction of rabbit platelets in the allergic response of sensitized leukocytes. I. Demonstration of a fluid phase intermediate. J Immunol (1971) 1.48
Effect of intravascular complement activation on granulocyte adhesiveness and distribution. Blood (1978) 1.31
Release of platelet-activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils. Immunology (1977) 1.25
Arachidonic acid induced degranulation of rabbit peritoneal neutrophils. Biochem Biophys Res Commun (1979) 1.14
IgE-induced release of a platelet-activating factor from rabbit lung. J Immunol (1975) 1.13
Phorbol myristate acetate: in vivo effects upon neutrophils, platelets, and lung. Am J Pathol (1980) 1.11
Evidence for the involvement of IgE-basophil system in acute serum sickness. Clin Exp Immunol (1976) 1.10
Cytochemical electron microscopic studies of the action of phorbol myristate acetate on platelets. Am J Pathol (1974) 1.08
Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils. Biochim Biophys Acta (1980) 1.08
A possible role of arachidonic acid in human neutrophil aggregation and degranulation. Am J Pathol (1979) 1.06
Chemotactic factors and the neutrophil. Semin Hematol (1979) 1.00
Platelet-activating factor. Monogr Allergy (1977) 0.96
Platelet activating factor (PAF). A possible direct mediator of anaphylaxis in the rabbit and a trigger for the vascular deposition of circulating immune complexes. Monogr Allergy (1977) 0.92
Neutrophil aggregation: evidence for a different mechanism of action by phorbol myristate acetate. Proc Soc Exp Biol Med (1980) 0.91
Specificity of lysophospholipase D. Biochim Biophys Acta (1980) 0.89
Intravascular effects of IgE antibody upon basophils,, neutrophils, platelets and blood coagulation in the rabbit. J Immunol (1975) 0.85
IgE-induced respiratory and circulatory changes during systemic anaphylaxis in the rabbit. Am Rev Respir Dis (1976) 0.81
Involvement of bivalent cations and arachidonic acid in neutrophil aggregation. Inflammation (1980) 0.79
Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol (1983) 5.07
Water Permeability of Bacterial Spores and the Concept of a Contractile Cortex. Science (1960) 4.13
Toxic fungi isolated from tall fescue. Mycopathol Mycol Appl (1967) 3.75
Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood (1976) 3.34
Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci (1967) 3.17
Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol (1982) 3.11
Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med (1995) 3.05
Synergistic combinations of penicillins in the treatment of bacteriuria. N Engl J Med (1967) 2.53
Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia (2001) 2.39
Consultant psychiatrists and abortion. Psychol Med (1974) 2.38
Consultant surgeons and vasectomy. Br Med J (1973) 2.35
A modified procedure for the determination of leukocyte alkaline phosphatase. Biochem Med (1970) 2.35
Neutrophil aggregation and swelling induced by chemotactic agents. J Immunol (1977) 2.26
Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy. J Med Chem (2001) 2.26
General practitioners and birth control advice in 1970-71. Br J Prev Soc Med (1972) 2.24
Reduction in pain associated with open carpal tunnel decompression. J Hand Surg Br (2000) 2.01
Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection. Appl Microbiol (1971) 2.01
Lincomycin: activity in vitro and absorption and excretion in normal young men. Am J Med Sci (1967) 2.00
In vitro quantitative chemical analysis of tattoo pigments. Arch Dermatol (2001) 1.96
Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes. Am J Pathol (1978) 1.91
Neutropenia induced by systemic infusion of chemotactic factors. J Immunol (1977) 1.89
New biological activity following intravascular activation of the complement cascade. Nature (1974) 1.89
Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest (1972) 1.85
Antibiotic prophylaxis of carriers of sulfadiazine-resistant meningococci. J Infect Dis (1966) 1.82
Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost (2003) 1.81
Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J Biol Chem (2000) 1.78
Selective neutrophil desensitization to chemotactic factors. J Cell Biol (1979) 1.77
Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid. J Biol Chem (1980) 1.73
MODIFICATION OF GRAMICIDIN THROUGH REACTION WITH FORMALDEHYDE. Science (1945) 1.69
Dissociation by colchicine of the hexose monophosphate shunt activation from the bactericidal activity of the leukocyte. Infect Immun (1971) 1.64
von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens (1993) 1.63
An isotopic assay for NADPH oxidase activity and some characteristics of the enzyme from human polymorphonuclear leukocytes. J Clin Invest (1975) 1.63
Release and metabolism of arachidonic acid in human neutrophils. J Biol Chem (1981) 1.62
1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J Biol Chem (1984) 1.59
Superoxide dismutase activity in leukocytes. J Clin Invest (1974) 1.59
Determination of dipicolinic acid in bacterial spores by ultraviolet spectrometry of the calcium chelate. Anal Biochem (1967) 1.58
Influence of inhibitors of cellular function on chemotactic factor-induced neutrophil aggregation. J Immunol (1977) 1.57
Inhibition of in vivo and in vitro neutrophil responses to chemotactic factors by a competitive antagonist. J Immunol (1978) 1.55
Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. J Clin Invest (1991) 1.54
Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection. J Exp Med (1969) 1.53
Initiation of the respiratory burst in human polymorphonuclear neutrophils: a critical review. J Reticuloendothel Soc (1978) 1.52
A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus. J Virol (1998) 1.51
The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts. J Immunol (1987) 1.49
Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis. J Clin Invest (1978) 1.49
Synergistic penicillin combinations for treatment of human urinary-tract infections. Antimicrob Agents Chemother (Bethesda) (1966) 1.48
A labile transcriptional repressor modulates endotoxin tolerance. J Exp Med (1994) 1.47
Oxidative metabolism of the human eosinophil. Blood (1977) 1.45
Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol (1986) 1.45
Comparison of human eosinophils from normals and patients with eosinophilia. J Clin Invest (1980) 1.44
Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor. J Clin Invest (1986) 1.44
Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils. J Biol Chem (1989) 1.42
Functional characteristics of human toxic neutrophils. J Infect Dis (1971) 1.41
Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes. J Clin Invest (1976) 1.41
Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. J Biol Chem (1982) 1.39
Evidence of protein kinase C involvement in phorbol diester-stimulated arachidonic acid release and prostaglandin synthesis. J Biol Chem (1987) 1.39
A novel mechanism of diglyceride formation. 12-O-tetradecanoylphorbol-13-acetate stimulates the cyclic breakdown and resynthesis of phosphatidylcholine. J Biol Chem (1986) 1.36
Extended-wear lenses, biofilm, and bacterial adhesion. Arch Ophthalmol (1987) 1.35
Studies on the mechanism of fatty acid synthesis. 13. The role of beta-hydroxy acids in the synthesis of palmitate and cis vaccenate by the Escherichia coli enzyme system. J Biol Chem (1966) 1.35
Hydrolysis of phospholipids and glycerides by rat-liver preparations. Biochim Biophys Acta (1967) 1.34
Quantitative comparisons of various biological responses of neutrophils to different active and inactive chemotactic factors. Immunopharmacology (1978) 1.33
Effect of intravascular complement activation on granulocyte adhesiveness and distribution. Blood (1978) 1.31
The phenotypic range of hemophilia A carriers. Am J Hum Genet (1976) 1.31
Cucumber sex expression modified by 2-chloroethanephosphonic acid. Science (1968) 1.29
Endothelial surface characteristics in pigeon coronary artery atherosclerosis. I. Cellular alterations during the initial stages of dietary cholesterol challenge. Lab Invest (1982) 1.27
Independent stimulation of motility and the oxidative metabolic burst of human polymorphonuclear leukocytes. J Immunol (1978) 1.27
Radiation-associated sarcoma: a review of 23 patients with postradiation sarcoma over a 50-year period. Am J Clin Oncol (1989) 1.26
Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J Biol Chem (1992) 1.26
Generation of chemiluminescence by a particulate fraction isolated from human neutrophils. Analysis of molecular events. J Clin Invest (1979) 1.26
Biosynthesis of platelet activating factor in rabbit polymorphonuclear neutrophils. J Biol Chem (1983) 1.26
Magnesium-dependent adenosine triphosphatase as a marker enzyme for the plasma membrane of human polymorphonuclear leukocytes. Infect Immun (1977) 1.25
Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem Biophys Res Commun (1992) 1.25
Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest (1980) 1.24
Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. Biochim Biophys Acta (1978) 1.24
Comparison of NADH and NADPH oxidase activities in granules isolated from human polymorphonuclear leukocytes with a fluorometric assay. J Clin Invest (1977) 1.22
Phagocytosis of live versus heat-killed bacteria by human polymorphonuclear leukocytes. Infect Immun (1974) 1.22
Genetic analysis of von Willebrand's disease in two large pedigrees: a multivariate approach. Am J Med Genet (1980) 1.22
Early atherogenesis in White Carneau pigeons. I. Leukocyte margination and endothelial alterations at the celiac bifurcation. Am J Pathol (1984) 1.22
Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome. N Engl J Med (1989) 1.22
The enzymic synthesis of ethanolamine plasmalogens. J Biol Chem (1971) 1.21
Characterization of the human interleukin 1 receptor on human polymorphonuclear leukocytes. Clin Immunol Immunopathol (1988) 1.20